Citation Tools
PDFLate-breaking abstracts
Combination immunotherapies
820 MCLA-145 is a bispecific IgG1 antibody that inhibits PD-1/PD-L1 signaling while simultaneously activating CD137 signaling on T cells
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- 820 MCLA-145 is a bispecific IgG1 antibody that inhibits PD-1/PD-L1 signaling while simultaneously activating CD137 signaling on T cells